Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;27(7):2481-2496.
doi: 10.1007/s40519-022-01388-5. Epub 2022 Mar 16.

Anti-hypothalamus autoantibodies in anorexia nervosa: a possible new mechanism in neuro-physiological derangement?

Affiliations

Anti-hypothalamus autoantibodies in anorexia nervosa: a possible new mechanism in neuro-physiological derangement?

Andrea Escelsior et al. Eat Weight Disord. 2022 Oct.

Abstract

Purpose: Anorexia nervosa (AN) is a serious and complex mental disorder affecting mainly young adult women. AN patients are characterized by low body weight in combination with self-induced starvation, intense fear of gaining weight, and distortion of body image. AN is a multifactorial disease, linked by recent evidence to a dysregulation of the immune system.

Methods: In this pilot study, 22 blood serums from AN patients were tested for the presence of autoantibodies against primate hypothalamic periventricular neurons by immunofluorescence and by a home-made ELISA assay. Cellular fluorescence suggests the presence of autoantibodies which are able to recognize these neurons (both to body cell and fiber levels). By means of ELISA, these autoantibodies are quantitatively evaluated. In addition, orexigenic and anorexigenic molecules were measured by ELISA. As control, 18 blood serums from healthy age matched woman were analysed.

Results: All AN patients showed a reactivity against hypothalamic neurons both by immunofluorescence and ELISA. In addition, ghrelin, pro-opiomelanocortin (POMC), and agouti-related peptide (AGRP) were significantly higher than in control serums (p < 0.0001). In contrast, leptin was significantly lower in AN patients than controls (p < 0.0001).

Conclusions: Immunoreaction and ELISA assays on AN blood serum suggest the presence of autoantibodies AN related. However, it is not easy to determine the action of these antibodies in vivo: they could interact with specific ligands expressed by hypothalamic cells preventing their physiological role, however, it is also possible that they could induce an aspecific stimulation in the target cells leading to an increased secretion of anorexigenic molecules. Further studies are needed to fully understand the involvement of the immune system in AN pathogenesis.

Level of evidence: V, descriptive study.

Keywords: Anorexia nervosa; Anorexigenic molecules; Autoimmunity; Hypothalamic autoantibodies; Orexigenic molecules.

PubMed Disclaimer

Conflict of interest statement

All the authors reported no medical financial interests or potential conflicts of interests.

Figures

Fig. 1
Fig. 1
IgG and IgM autoantibody standard curves. IgG and IgM autoantibodies ELISA standard curves used to calculate the anti-hypothalamus antibodies concentrations in human subject serum. In (A) IgG standard curve and in (B) IgM standard curve are presented. Standard deviation (STD) from three independent runs were shown. Linear regression fitting results (continuous line) and 95% confidence bands of the best-fit line (dotted line) are shown
Fig. 2
Fig. 2
Serum from AN patients show an immune-reaction against hypothalamic cells. Immunofluorescent detection of binding of immunoglobulin G autoantibodies from 22 patients with AN to a primate hypothalamus section at the level of the arcuate nucleus (Pz 1, 2 and 8 are presented of examples of score 3 immunoreactive pattern, and Pz 10 of score 2). As control, 3 out 18 representative sera from healthy control are shown (Ctr1-3 as examples of score 0, and Ctr7 and Crt9 of score 1). The experiment was repeated four times. In the graph, the different reactivity among AN and healthy control is statistical different. The intensity of the fluorescence was determined by two different readers blind to subject characteristics and a scale from 0 to 3 was assigned (0 no reaction, 1 uncertain fluorescence, 2 nuclear fluorescence, 3 fibers and/or nuclear fluorescence). Samples scored positive if a 2 or 3 fluorescence reaction was observed
Fig. 3
Fig. 3
Anti-hypothalamic antibody IgG levels are present in sera from AN patients. A measurable anti-hypothalamic IgG antibody level is present exclusively in AN patients (Panel A). The amount of anti-hypothalamic IgG antibody correlates positively with the intensity of fluorescence on hypothalamus section (Panel B)
Fig. 4
Fig. 4
Orexigenic and anorexigenic molecules evaluation. A comparison of plasma ghrelin, POMC, AGRP and leptin levels in women with AN and healthy control women are shown
Fig. 5
Fig. 5
Correlation analysis among the amount of orexigenic and anorexigenic molecules was performed
Fig. 6
Fig. 6
Correlation analysis among the amount of orexigenic and anorexigenic molecules and anti-hypothalamic antibodies evaluated by immunofluorescence (left panels) and ELISA (right panels)
Fig. 7
Fig. 7
Analysis of the correlation among ghrelin, POMC, ARGP, leptin, and fluorescent intensity (IFI) with BMI
Fig. 8
Fig. 8
Orexigenic and anorexigenic molecules are able to interfere with autoantibodies binding. As orexigenic and anorexigenic molecules are thought to play prominent roles in integration of peripheral and central signals to modulate appetite and metabolism, experiments were set up to investigate whether they may interfere with the binding of reactive autoantibodies to hypothalamic tissues. All 22 AN sera were titred alone and in presence of recombinant human soluble molecules of ghrelin, POMC, AGRP, and α-MSH

Similar articles

Cited by

References

    1. Treasure J, Zipfel S, Micali N, et al. Anorexia nervosa. Nat Rev Dis Primers. 2015;1:15074. doi: 10.1038/nrdp.2015.74. - DOI - PubMed
    1. Zipfel S, Giel KE, Bulik CM, Hay P, Schmidt U. Anorexia nervosa: aetiology, assessment, and treatment. Lancet Psychiatry. 2015;2:1099–1111. doi: 10.1038/nrdp.2015.74. - DOI - PubMed
    1. Kaye WH, Wierenga CE, Bailer UF, Simmons AN, Bischoff-Grethe A. Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa. Trends Neurosci. 2013;36:110–120. doi: 10.1016/j.tins.2013.01.003. - DOI - PMC - PubMed
    1. Giovinazzo S, Sukkar SG, Rosa GM, et al. Anorexia nervosa and heart disease: a systematic review. Eat Weight Disord. 2019;24:199–207. doi: 10.1007/s40519-018-0567-1. - DOI - PubMed
    1. Schorr M, Miller KK. The endocrine manifestations of anorexia nervosa: mechanisms and management. Nat Rev Endocrinol. 2017;13:174–186. doi: 10.1038/nrendo.2016.175. - DOI - PMC - PubMed

Supplementary concepts